Humana recently changed how frequently we reimburse cervical and vaginal screening services for average-risk women age 21 or older. For commercial and Medicaid members, we limit reimbursement to once every three years, and for Humana Medicare Advantage members, the limit is once every two years. This change does not apply to women with a high-risk diagnosis.
We are making this change to align with recommendations from the American College of Obstetricians and Gynecologists (ACOG) and the U.S. Preventive Services Task Force (USPSTF). Annual cervical or vaginal screenings are no longer recommended for women 21 and older because clinical evidence does not show an advantage over performing screenings at three-year intervals for average-risk women. Screenings are not recommended for women younger than 21 because cervical cancer is rare in young women and screening leads to unnecessary treatment which increases the risk of reproductive problems.